Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02694848
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02694848
-
- Other papers using this trial's data
- Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02694848. Randomized; single masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
- Condition
- Angina
- Intervention (Drug)
- Salvianolate injection
- Intervention (Drug)
- Aspirin
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Collaborator
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- General Hospital of Beijing PLA Military Region
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct02694848- Content hash
89946c4f6e28f386402de4909d0c857d9f8119eb31d5c87bc6d251430deca241